Literature DB >> 28841414

Reprogramming Enhancers to Drive Metastasis.

Raul Mostoslavsky1, Nabeel Bardeesy2.   

Abstract

Acquired molecular changes can promote the spreading of primary tumor cells to distant tissues. In this issue of Cell, Roe et al. show that metastatic progression of pancreatic cancer involves large-scale enhancer reprogramming by Foxa1, which activates transcriptional program specifying early endodermal stem cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28841414     DOI: 10.1016/j.cell.2017.08.010

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  6 in total

1.  Epigenetic plasticity of enhancers in cancer.

Authors:  Jie Yao; Ji Chen; Lian-Yun Li; Min Wu
Journal:  Transcription       Date:  2020-01-16

2.  CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.

Authors:  Lu Wang; Guang Yang; Danfeng Zhao; Jiaqi Wang; Yang Bai; Qiang Peng; Hongzhi Wang; Ruizhe Fang; Guang Chen; Zhichao Wang; Keliang Wang; Guangbin Li; Yinhui Yang; Ziqi Wang; Pengyu Guo; Li Peng; Dayong Hou; Wanhai Xu
Journal:  Mol Cancer       Date:  2019-04-11       Impact factor: 27.401

3.  Disruption of Broad Epigenetic Domains in PDAC Cells by HAT Inhibitors.

Authors:  Diana L Gerrard; Joseph R Boyd; Gary S Stein; Victor X Jin; Seth Frietze
Journal:  Epigenomes       Date:  2019-06-02

Review 4.  Role of Enhancers in Development and Diseases.

Authors:  Shailendra S Maurya
Journal:  Epigenomes       Date:  2021-10-04

Review 5.  Exploring the links between cancer and placenta development.

Authors:  Vincenzo Costanzo; Alberto Bardelli; Salvatore Siena; Sergio Abrignani
Journal:  Open Biol       Date:  2018-06       Impact factor: 6.411

6.  TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT.

Authors:  Mengya Zhong; Maoshu Zhu; Yu Liu; Ying Lin; Lianghai Wang; Yuhan Ye; Huiyu Chen; Yan Yang; Guohong Zhuang; Jiyi Huang
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.